These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 22161865
1. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. Xu B, Wang N, Wang X, Tong N, Shao N, Tao J, Li P, Niu X, Feng N, Zhang L, Hua L, Wang Z, Chen M. Prostate; 2012 Aug 01; 72(11):1171-8. PubMed ID: 22161865 [Abstract] [Full Text] [Related]
2. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. Sun Q, Zhao X, Liu X, Wang Y, Huang J, Jiang B, Chen Q, Yu J. Prostate; 2014 Dec 01; 74(16):1613-21. PubMed ID: 25214035 [Abstract] [Full Text] [Related]
3. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Ma S, Chan YP, Kwan PS, Lee TK, Yan M, Tang KH, Ling MT, Vielkind JR, Guan XY, Chan KW. Cancer Res; 2011 Jan 15; 71(2):583-92. PubMed ID: 21224345 [Abstract] [Full Text] [Related]
4. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1. Xu B, Huang Y, Niu X, Tao T, Jiang L, Tong N, Chen S, Liu N, Zhu W, Chen M. Prostate; 2015 Dec 15; 75(16):1896-903. PubMed ID: 26306811 [Abstract] [Full Text] [Related]
5. Clinical significance of miR-146a in gastric cancer cases. Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clin Cancer Res; 2011 Jul 01; 17(13):4277-84. PubMed ID: 21632853 [Abstract] [Full Text] [Related]
6. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T. Oncogene; 2012 Oct 11; 31(41):4460-71. PubMed ID: 22266859 [Abstract] [Full Text] [Related]
7. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Liu D, Tao T, Xu B, Chen S, Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X, Huang X, Zhang L, Han C, Chen M. Biochem Biophys Res Commun; 2014 Feb 28; 445(1):151-6. PubMed ID: 24491557 [Abstract] [Full Text] [Related]
8. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS, Zhao YL, Mao XH, Guo G, Yu PW, Zou QM. Oncol Rep; 2012 Feb 28; 27(2):559-66. PubMed ID: 22020746 [Abstract] [Full Text] [Related]
9. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. Clin Cancer Res; 2011 Aug 15; 17(16):5287-98. PubMed ID: 21159887 [Abstract] [Full Text] [Related]
10. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O. Cancer Res; 2011 Mar 01; 71(5):1956-67. PubMed ID: 21343391 [Abstract] [Full Text] [Related]
11. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H. Prostate; 2014 May 01; 74(7):756-67. PubMed ID: 24644030 [Abstract] [Full Text] [Related]
12. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL. Carcinogenesis; 2013 Mar 01; 34(3):530-8. PubMed ID: 23188675 [Abstract] [Full Text] [Related]
13. microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Hou Z, Yin H, Chen C, Dai X, Li X, Liu B, Fang X. Mol Med Rep; 2012 Sep 01; 6(3):501-6. PubMed ID: 22711166 [Abstract] [Full Text] [Related]
14. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Mol Cancer Res; 2011 Jun 01; 9(6):791-800. PubMed ID: 21593139 [Abstract] [Full Text] [Related]
15. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y. Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913 [Abstract] [Full Text] [Related]
16. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF. Prostate; 2010 Apr 01; 70(5):467-72. PubMed ID: 19902466 [Abstract] [Full Text] [Related]
17. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC. Cancer Res; 2008 Aug 01; 68(15):6407-15. PubMed ID: 18676866 [Abstract] [Full Text] [Related]
18. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG, Zaffaroni N. Cancer Res; 2009 Mar 15; 69(6):2287-95. PubMed ID: 19244118 [Abstract] [Full Text] [Related]
19. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55. You B, Zhang KC. Eur Rev Med Pharmacol Sci; 2018 Nov 15; 22(22):7660-7670. PubMed ID: 30536308 [Abstract] [Full Text] [Related]
20. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Shiota M, Takeuchi A, Song Y, Yokomizo A, Kashiwagi E, Uchiumi T, Kuroiwa K, Tatsugami K, Fujimoto N, Oda Y, Naito S. Endocr Relat Cancer; 2011 Aug 15; 18(4):505-17. PubMed ID: 21652770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]